Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.
Aukera Therapeutics has raised $5.7M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Aukera Therapeutics's investors include Zürcher Kantonal Bank, Venture Kick, Kickfund, BaseLaunch.
Aukera Therapeutics is headquartered in Basel, Switzerland.
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.
Aukera Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aukera Therapeutics — Funding & Investors." VCBacked, December 11, 2025, https://www.vcbacked.co/company/aukera-therapeutics. Accessed July 20, 2026.
VCBacked. (2025). Aukera Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/aukera-therapeutics
{{cite web |title=Aukera Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aukera-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated